Literature DB >> 15258091

Pathogenesis of malaria and clinically similar conditions.

Ian A Clark1, Lisa M Alleva, Alison C Mills, William B Cowden.   

Abstract

There is now wide acceptance of the concept that the similarity between many acute infectious diseases, be they viral, bacterial, or parasitic in origin, is caused by the overproduction of inflammatory cytokines initiated when the organism interacts with the innate immune system. This is also true of certain noninfectious states, such as the tissue injury syndromes. This review discusses the historical origins of these ideas, which began with tumor necrosis factor (TNF) and spread from their origins in malaria research to other fields. As well the more established proinflammatory mediators, such as TNF, interleukin-1, and lymphotoxin, the roles of nitric oxide and carbon monoxide, which are chiefly inhibitory, are discussed. The established and potential roles of two more recently recognized contributors, overactivity of the enzyme poly(ADP-ribose) polymerase 1 (PARP-1) and the escape of high-mobility-group box 1 (HMGB1) protein from its normal location into the circulation, are also put in context. The pathogenesis of the disease caused by falciparum malaria is then considered in the light of what has been learned about the roles of these mediators in these other diseases, as well as in malaria itself.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258091      PMCID: PMC452556          DOI: 10.1128/CMR.17.3.509-539.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  443 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

Review 3.  Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.

Authors:  F B Taylor
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.

Authors:  S Cuzzocrea; E Mazzon; L Dugo; A Barbera; T Centorrino; A Ciccolo; M T Fonti; A P Caputi
Journal:  Shock       Date:  2001-07       Impact factor: 3.454

5.  Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock.

Authors:  M Ombrellino; H Wang; M S Ajemian; A Talhouk; L A Scher; S G Friedman; K J Tracey
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

6.  Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats.

Authors:  C A Sims; S Wattanasirichaigoon; M J Menconi; A M Ajami; M P Fink
Journal:  Crit Care Med       Date:  2001-08       Impact factor: 7.598

7.  Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction.

Authors:  P Bobé; K Benihoud; D Grandjon; P Opolon; L L Pritchard; R Huchet
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

8.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

9.  Inducible nitric oxide synthase is not required in the development of endotoxin tolerance in mice.

Authors:  Basilia Zingarelli; Paul W Hake; James A Cook
Journal:  Shock       Date:  2002-06       Impact factor: 3.454

10.  Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.

Authors:  J R Thistlethwaite; A B Cosimi; F L Delmonico; R H Rubin; N Talkoff-Rubin; P W Nelson; L Fang; P S Russell
Journal:  Transplantation       Date:  1984-12       Impact factor: 4.939

View more
  65 in total

1.  Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya.

Authors:  John N Waitumbi; Jane Kuypers; Samuel B Anyona; Joseph N Koros; Mark E Polhemus; Jay Gerlach; Matthew Steele; Janet A Englund; Kathleen M Neuzil; Gonzalo J Domingo
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.

Authors:  Robin Kobbe; Nadine Schreiber; Jürgen May; Thomas Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

3.  Evolution of parasite virulence when host responses cause disease.

Authors:  Troy Day; Andrea L Graham; Andrew F Read
Journal:  Proc Biol Sci       Date:  2007-11-07       Impact factor: 5.349

Review 4.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

5.  Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.

Authors:  Hélène Savini; Jean Baptiste Souraud; Sébastien Briolant; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 6.  [Malaria].

Authors:  G Burchard
Journal:  Internist (Berl)       Date:  2006-08       Impact factor: 0.743

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  The lipid moiety of haemozoin (Malaria Pigment) and P. falciparum parasitised red blood cells bind synthetic and native endothelin-1.

Authors:  Nicoletta Basilico; Silvia Parapini; Francesca Sisto; Fausta Omodeo-Salè; Paolo Coghi; Fernando Ravagnani; Piero Olliaro; Donatella Taramelli
Journal:  J Biomed Biotechnol       Date:  2010-02-24

9.  VEGF promotes malaria-associated acute lung injury in mice.

Authors:  Sabrina Epiphanio; Marta G Campos; Ana Pamplona; Daniel Carapau; Ana C Pena; Ricardo Ataíde; Carla A A Monteiro; Nuno Félix; Artur Costa-Silva; Claudio R F Marinho; Sérgio Dias; Maria M Mota
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

10.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.